Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Sanara MedTech (SMTI) EBT (2016 - 2025)

Historic EBT for Sanara MedTech (SMTI) over the last 15 years, with Q3 2025 value amounting to $1.1 million.

  • Sanara MedTech's EBT rose 85357.96% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.1 million, marking a year-over-year decrease of 9332.38%. This contributed to the annual value of -$9.8 million for FY2024, which is 12121.86% down from last year.
  • Latest data reveals that Sanara MedTech reported EBT of $1.1 million as of Q3 2025, which was up 85357.96% from -$1.8 million recorded in Q2 2025.
  • Sanara MedTech's 5-year EBT high stood at $1.1 million for Q3 2025, and its period low was -$7.0 million during Q4 2024.
  • Its 5-year average for EBT is -$2.2 million, with a median of -$1.9 million in 2023.
  • Its EBT has fluctuated over the past 5 years, first plummeted by 256839.06% in 2024, then soared by 85357.96% in 2025.
  • Quarter analysis of 5 years shows Sanara MedTech's EBT stood at -$3.6 million in 2021, then fell by 17.06% to -$4.2 million in 2022, then soared by 93.7% to -$262444.0 in 2023, then plummeted by 2568.39% to -$7.0 million in 2024, then surged by 116.04% to $1.1 million in 2025.
  • Its EBT was $1.1 million in Q3 2025, compared to -$1.8 million in Q2 2025 and -$3.4 million in Q1 2025.